North Carolina lawmakers approved a final deal Wednesday to protect some, but not all, of the state’s 340B covered entities against discrimination by pharmacy benefit managers (PBMs).
Under an agreement a House-Senate conference committee reached on Sept. 8, 340B disproportionate share hospitals, children’s hospitals, free-standing cancer hospitals, and hemophilia treatment centers were excluded from protection against discriminatory PBM treatment under the Medication Cost Transparency Act, SB 257. Certain insurance companies pressed hard for their exclusion, lobbyists said.
North Carolina lawmakers approved a final deal Wednesday to protect some, but not all, of the state’s 340B covered entities against discrimination by pharmacy benefit managers (PBMs).
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
